feed,title,long_url,short_url
Benzinga,FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic Disorder,https://benzinga.com/general/biotech/24/02/37368043/fda-grants-review-date-for-applied-therapeutics-first-commercial-product-for-rare-metabolic-disor,https://da.gd/3Kf5W
Benzinga,Market Analysis: Costco Wholesale And Competitors In Consumer Staples Distribution & Retail Industry,https://benzinga.com/insights/news/24/02/37368030/market-analysis-costco-wholesale-and-competitors-in-consumer-staples-distribution-amp-retail-indust,https://da.gd/jqGn
Benzinga,Comparative Study: Comcast And Industry Competitors In Media Industry,https://benzinga.com/insights/news/24/02/37368025/comparative-study-comcast-and-industry-competitors-in-media-industry,https://da.gd/qtp8OQ
Benzinga,Analyzing Merck & Co In Comparison To Competitors In Pharmaceuticals Industry,https://benzinga.com/insights/news/24/02/37368022/analyzing-merck-amp-co-in-comparison-to-competitors-in-pharmaceuticals-industry,https://da.gd/J4JiN
Benzinga,Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years,https://benzinga.com/insights/news/24/02/37368020/heres-how-much-you-would-have-made-owning-abbvie-stock-in-the-last-10-years,https://da.gd/Ev13
Benzinga,Here's How Much $1000 Invested In Moody's 15 Years Ago Would Be Worth Today,https://benzinga.com/insights/news/24/02/37368016/heres-how-much-1000-invested-in-moodys-15-years-ago-would-be-worth-today,https://da.gd/UvaD
Benzinga,"Palatin Technologies' Disappointing Data From Dry Eye Disease Study, Stock Plummets",https://benzinga.com/general/biotech/24/02/37367897/palatin-technologies-disappointing-data-from-dry-eye-disease-study-stock-plummets,https://da.gd/g6pJoe
